You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 9, March 3, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Psychiatry
 •Adverse Effects
 •Alert me on articles by topic

Olanzapine vs Haloperidol for Treatment of Schizophrenia—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Volavka and Citrome suggest that some patients in our study may have previously failed to improve with atypical antipsychotic drugs, thus biasing our results in favor of a negative effect of olanzapine. We think this conclusion is unlikely. We did not find that olanzapine was less effective in our study than in others, but rather that haloperidol was so much better, probably because we provided prophylactic benztropine. In fact, at entry into our study, 40% of patients were receiving an atypical antipsychotic, 37% were receiving haloperidol, and the rest were receiving other conventional agents. If anything, this would have biased the results against haloperidol, not olanzapine. Volavka et al1 have previously acknowledged that the findings of their study favoring olanzapine were invalid because " . . . we included patients who had failed to respond to haloperidol. However, those who showed a clear failure to respond to . . . [Full Text of this Article]

Robert Rosenheck, MD; Deborah Perlick, PhD; Stephen Bingham, PhD; Joseph Collins, ScD
West Haven, Conn


RELATED ARTICLES

Olanzapine vs Haloperidol for Treatment of Schizophrenia
Jan Volavka and Leslie Citrome
JAMA. 2004;291(9):1064.
EXTRACT | FULL TEXT  

Olanzapine vs Haloperidol for Treatment of Schizophrenia
William M. Glazer
JAMA. 2004;291(9):1064-1065.
EXTRACT | FULL TEXT  

Olanzapine vs Haloperidol for Treatment of Schizophrenia
Mo Amin and Vijay S. Shukla
JAMA. 2004;291(9):1065.
EXTRACT | FULL TEXT  

Olanzapine vs Haloperidol for Treatment of Schizophrenia
Michal Kunz
JAMA. 2004;291(9):1065.
EXTRACT | FULL TEXT  

Olanzapine vs Haloperidol for Treatment of Schizophrenia
Lieuwe de Haan and Nico van Beveren
JAMA. 2004;291(9):1065.
EXTRACT | FULL TEXT  

Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia: A Randomized Controlled Trial
Robert Rosenheck, Deborah Perlick, Stephen Bingham, Wen Liu-Mares, Joseph Collins, Stuart Warren, Douglas Leslie, Edward Allan, E. Cabrina Campbell, Stanley Caroff, June Corwin, Lori Davis, Richard Douyon, Lawrence Dunn, Denise Evans, Ede Frecska, John Grabowski, David Graeber, Lawrence Herz, Kong Kwon, William Lawson, Felicitas Mena, Javaid Sheikh, David Smelson, and Valerie Smith-Gamble
JAMA. 2003;290(20):2693-2702.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.